DelveInsight’s “Functional Constipation Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Functional Constipation market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The report covers emerging Functional Constipation drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Functional Constipation treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Functional Constipation: An Overview
Functional Constipation (FC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. Functional Constipation is also referred to as chronic idiopathic constipation (CIC), as Functional Constipation is classified as one of the functional gastrointestinal disorders (FGDs). It is estimated that approximately 14% of the population experiences chronic constipation. Possible Functional Constipation causes could be a reduction in fluid and fiber intake in the diet, changes in water balance, and changes in contractility of the colon.
Functional Constipation is characterized by infrequent stools which are often difficult to pass. It typically affects women and older adults. The typical symptom of this condition is passing fewer than three bowel movements per week for more than six months.
The symptoms of Functional Constipation include infrequent bowel movements, straining, hard or lumpy stools, feeling of incomplete evacuation, abdominal pain or discomfort, bloating, gas pain, vomiting, blood in the stool, anemia, etc. These symptoms are more likely to indicate a serious underlying condition in people who are over 50 years of age at the time of symptoms first appear.
Functional Constipation Market Key Facts
-
As per ADA Health, eight million people in the US seek medical care for constipation every year, and one million are hospitalized. It is likely that many people who have Functional Constipation do not report the condition to their doctors because they are embarrassed or do not see it as a major problem requiring medical care.
-
As per a 2011 study conducted by Suares et al. titled “Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis” which found that out of the 100 papers evaluated, 45 reported the prevalence of Functional Constipation in 41 separate study populations, containing 261,040 subjects with a pooled prevalence of Functional Constipation in all studies was 14%. They also found that the prevalence of Functional Constipation was higher in women and increased with age and lower socioeconomic status.
-
According to the 2018 study conducted by Black et al. titled “Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management” stated that the prevalence of Functional Constipation increases with age, with higher rates reported in older people.
Functional Constipation Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Functional Constipation pipeline therapies. It also thoroughly assesses the Functional Constipation market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete details of the market trend for each marketed Functional Constipation drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.
Functional Constipation Epidemiology Assessment
The epidemiology section provides insights into the historical, current, and forecasted Functional Constipation epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted Functional Constipation epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pools, future trends, and views of key opinion leaders.
The Report Covers the Functional Constipation Epidemiology, Segmented as –
-
Prevalent Population of Functional Constipation (2019–2032)
-
Age-specific Prevalent Population of Functional Constipation (2019–2032)
-
Gender-specific Prevalent Population of Functional Constipation (2019–2032)
-
Diagnosed and Treatable Cases of Functional Constipation (2019–2032)
Functional Constipation Drugs Uptake and Pipeline Development Activities
The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Functional Constipation market or expected to be launched during the study period. The analysis covers the Functional Constipation market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the market dynamics by drug sales, the most rapid drug uptake, and the reasons behind the maximal use of particular drugs. Additionally, it compares the Functional Constipation drugs based on their sale and market share.
The report also covers the Functional Constipation pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key Functional Constipation companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How the Functional Constipation Market Will Evolve and Grow by 2032 @
https://www.delveinsight.com/sample-request/functional-constipation-market
Functional Constipation Therapeutics Analysis
The dynamics of the Functional Constipation treatment paradigm have a major obstacle where the exact cause is still not known due to which it is not possible to determine definitive treatment for the indication. Although there are several approved drugs for Functional Constipation, still a need for developing targeted therapies.
The treatment options for Functional Constipation include Dietary Fiber, Laxatives, and Medications. The major difficulty faced by patients suffering from Functional Constipation is a lack of proper digestion, which results in the hardening of the stools. It is advised to intake large amounts of water to soften the stools along with modifications in the diet, which is rich in fiber so that there is an improvement in digestion.
Stool softeners are used to avoid straining when the patient has a movement, like after surgery. They are best for short-term use. They work by pulling in water from your intestines to soften your stool. Docusate (Colace, DulcoEase, Surfak) is a commonly used stool softener.
There are several FDA-approved drugs that are also available to treat FC, which include Motegrity (Prucalopride), Linzess (linaclotide), and Trulance (plecanatide) by Takeda, Allergan, and Synergy Pharmaceuticals, respectively.
The pipeline for Functional Constipation exhibits a high medical unmet need for better treatment alternatives with prominent emerging drugs in the future. The current scenario also anticipates a positive shift in the market for a study period of 2-19-32.
Functional Constipation Companies Actively Working in the Therapeutics Market Include
-
Renexxion
-
Gelesis
And Many Others
Emerging and Marketed Functional Constipation Therapies Covered in the Report Include:
-
Naronapride: Renexxion
-
GS500: Gelesis
And Many More
Download the Sample Report to Learn More About the Key Companies and Emerging Therapies @
https://www.delveinsight.com/sample-request/functional-constipation-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Functional Constipation Competitive Intelligence Analysis
4. Functional Constipation Market Overview at a Glance
5. Functional Constipation Disease Background and Overview
6. Functional Constipation Patient Journey
7. Functional Constipation Patient Population and Epidemiology Trends (In the US, EU5, and Japan)
8. Functional Constipation Treatment Algorithm, Current Treatment, and Medical Practices
9. Functional Constipation Unmet Needs
10. Key Endpoints of Functional Constipation Treatment
11. Functional Constipation Marketed Therapies
12. Functional Constipation Emerging Drugs and Latest Therapeutic Advances
13. Functional Constipation Seven Major Market Analysis
14. Attribute Analysis
15. Functional Constipation Market Outlook (In US, EU5, and Japan)
16. Functional Constipation Companies Active in the Market
17. Functional Constipation Access and Reimbursement Overview
18. KOL Views on the Functional Constipation Market
19. Functional Constipation Market Drivers
20. Functional Constipation Market Barriers
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Request the Sample PDF to Learn More About the Key Offerings of the Report @
https://www.delveinsight.com/sample-request/functional-constipation-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
“Musculoskeletal Pain Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Musculoskeletal Pain market size, share, trends, and growth analysis in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. Moreover, it also covers the current treatment practices, emerging drugs, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the Musculoskeletal Pain market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/oncology